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Abstract—Truncated sialylated O-glycans, such as cell-
surface carbohydrate antigen sialyl-Tn (STn) are overexpressed 
by several cancer types, but not by the respective normal tissues. 
STn expression is associated with oncogenesis and metastatic 
ability of cancer cells, with reduced overall survival and lack of 
response to chemotherapy. Advances in nanomedicine have 
resulted in rapid development of biocompatible 
superparamagnetic iron oxide nanoparticles (SPIONs) with 
considerable potential in cancer treatment. Therefore, in this 
study SPIONs coated with oleic acid (OA) or dimercaptosuccinic 
acid (DMSA) were developed and characterized for 
internalization in two breast cancer cell lines: cell line expressing 
the STn antigen and the corresponding control. SPIONs with an 
average diameter of 8 nm showed superparamagnetic behavior 
and high potential to be used as magnetic hyperthermia agents. 
OA and DMSA coating provided high stability of SPIONs in 
physiological conditions while not changing their main 
properties. NPs internalization studies showed a higher 
accumulation of DMSA coated NPs in the breast cancer MDA-
MB-231 WT cell line. In MDA-MB-231 cell line expressing STn 
both coated NPs showed a similar accumulation. Therefore, STn 
antigen can act as a receptor capable of detecting and covalently 
bind to the molecules present on NPs surface and induce their 
cellular uptake by endocytosis. 
 
I. INTRODUCTION  
Breast cancer is the most common malignancy in women 
throughout the world, accounting for more than 25 % of all 
new cancer diagnoses in 2012, and despite significant 
improvements in treatment, for 522,000 deaths [1]. The cell-
surface carbohydrate antigen STn, which is not observed in 
normal healthy tissues, is overexpressed in 30-40 % of early 
stage cases of breast cancer and so it is considered an excellent 
candidate to target initial phases of malignancy [2]. STn 
expression modulate a malignant phenotype inducing a more 
aggressive cell behavior in breast carcinoma cells. These facts 
clearly indicate the need to improve existing cancer treatments 
and to develop new therapeutic strategies. Nanomedicine, the 
application of nanotechnology to medicine, is a promising 
approach for specific cancer cell targeting, diagnosis, and 
treatment [3]. Among the nanotechnology tools investigated 
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for biomedical applications SPIONs have received a lot of 
attention in the last decades because of their outstanding 
magnetic properties, namely superparamagnetism. In 
particularly they are used as contrast agents for magnetic 
resonance imaging (MRI), as cell labeling agents for cell 
tracking, as drug delivery carriers and to induce magnetic 
hyperthermia [4,5]. Recently, hybrid NPs formulations with 
SPION cores modified with exterior coatings and functional 
probes have been created for their ability to enhance negative 
contrast in alternative imaging techniques in addition to MRI 
[6]. 
Hyperthermia therapy, an adjuvant medical treatment 
using global or local temperature elevation in tumor tissues, 
has been successfully applied alone or in combination with 
radiation and chemotherapy as a cancer treatment tool. This 
treatment is based on the higher sensitivity of cancer cells, 
which exhibit compact, disorganized and permeable vascular 
networks and poor blood flow and retain heat better than viable 
cells, therefore decreasing the side effects in the normal tissues 
[7]. In the last few years, research has focused on the injection 
of magnetic fluids directly into the tumor body, or into an 
artery supplying the tumor. The method relies on the theory 
that after localization of SPIONs near the cancer site using 
magnetic targeting, an alternating magnetic field (AMF) is 
applied to induce heat of about 42–45ºC for initiating 
apoptosis in cancer cells. This temperature increase can be 
controlled by manipulating the corresponding magnetic 
properties of NPs and the applied AMF [8]. 
In this work we studied the influence of OA and DMSA on 
the stability of colloidal solutions containing iron oxide 
(Fe3O4) NPs for further cellular uptake studies in breast cancer 
cells. This surface stabilization protects the magnetic core 
against oxidation and avoid the generation of reactive oxygen 
species (ROS) upon exposure of cells to SPIONs, preventing 
cytotoxicity effects [9]. The focus of this study was to design 
and develop nanostructures based on iron oxide nanoparticles 
stable in physiological conditions and able to generate heat 
under the application of an external magnetic field. The 
interaction of OA and DMSA Fe3O4 NPs was evaluated 
through cytotoxicity assays and cellular internalization of 
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these nanostructures in two breast cancer cell lines: MDA-
MB-231 WT and STn-expressing MDA-MB-231.  
II. MATERIALS & METHODS 
SPIONs synthesis was performed through chemical co-
precipitation which gives a careful control of the reaction 
parameters, like size and shape [10]. To obtain stable 
nanoparticles, OA and DMSA were used as coating molecules 
since they allow high stability of the nanoparticles in aqueous 
media and have free ligand groups for further biomolecule 
conjugation. OA was added to the NPs suspension as a 
percentage of the NPs mass. The mixture reacted during 4 
hours in ultrasound bath. These NPs will be referenced as OA 
Fe3O4 NPs. Before coating the NPs with DMSA, the pH of the 
suspension was adjusted to pH 3 with nitric acid 65% under 
magnetic agitation. DMSA was added immediately at a 4% 
ratio of [DMSA]/[Fe2+] [11]. DMSA was dissolved in 10 mL 
of deionized water and the pH adjusted to 5.5 with 0.1 M 
NaOH solution under vigorous stirring. The reaction of DMSA 
with NPs was performed in ultrasound bath for 4 hours. To 
characterize the stabilized SPIONs the following techniques 
were used: X-ray Diffraction (XRD) and Fourier Transform 
Infrared (FTIR) spectrometry to evaluate the structural and 
physical properties, UV-Vis spectrophotometry to evaluate the 
colloidal stability, Transmission electron microscopy (TEM) 
to evaluate the morphology, Vibrating sample magnetomer 
(VSM) to verify the magnetic properties and Dynamic light 
scattering (DLS) to measure the particles sizes in solution. 
Magnetic hyperthermia measurements were performed using 
a DM100 series from Nb Nanoscale Biomagnetics apparatus. 
Cell viability was determined using the MTS assay 
colorimetric method that measure mitochondrial activity. 
Cellular targeting and uptake of SPIONs were assessed by 
qualitative and quantitative studies that shows the effect of 
SPIONs molecular coatings in cellular uptake. For qualitative 
studies, Prussian Blue Staining technique was performed [12]. 
This method reveals the visual uptake of nanoparticles through 
bright field microscopy while 1,10-phenantroline colorimetric 
method was used to evaluate SPIONs internalization in a 
quantitative way indicating the iron uptake by cells. 
III.  RESULTS & DISCUSSION 
A. Iron oxide nanoparticles characterization 
One of the biggest concerns related to the use of 
nanostructures in biomedical applications include their 
stability in aqueous solution as well as their biocompatibility 
in cells/tissues. In this work, SPIONs were surface modified 
using OA and DMSA as stabilizers agents. SPIONs were 
synthesized by chemical co-precipitation with an average core 
diameter of 8 nm as showed in Fig. 1. Physicochemical 
characterization allowed the confirmation and identification of 
crystal structure preservation and the main chemical bonds 
formed after the Fe3O4 NPs surface. For a 64 % OA 
concentration, Fe3O4 NPs have a hydrodynamic diameter of 
147.3 ± 5.5 nm and DMSA (4 %) coated Fe3O4 NPs obtained 
a 57.1 ± 1.7 nm diameter, with a polydispersity index (PDI) of 
0.25 ± 0.02 and 0.20 ± 0.01, respectively. 
Thus, we concluded that both coating molecules provided 
high stability of SPIONs in physiological conditions while not 
changing their main properties although the nanoparticles 
hydrodynamic diameter is significantly higher for those 
stabilized with OA compared to DMSA. Table I summarizes 
the properties of the studied samples. Naked iron oxide NPs 
exhibit a magnetic saturation (MS) of around 57 emu.g−1 Fe at 
320 K. While DMSA does not change the magnetic saturation 
of the NPs, OA reduces the MS of the NPs to 45 emu.g−1. This 
suggests that the surfactant is reducing the magnetic moments 
at the surface of the NPs probably due to the diamagnetic 
contribution of OA volume. The surface atoms to volume ratio 
in NPs increases and consequently reduces the saturation 
magnetization [13]. Fig. 2 (A) represents the hysteresis loops 
of naked NPs and Fe3O4 NPs coated with 64 % OA and 4 % 
DMSA, measured at 320 K. For both cases it is evident the 
absence of coercivity and remanence at 320 K, which confirms 
the superparamagnetic behavior of all samples above the 
blocking temperature. In all cases, the magnetic domains are 
not separate by domain walls (multidomain state). Instead, 
each particle represents a single magnetic domain [14]. 
 
Figure 1.  TEM images of (A) naked (8.0 ± 2.1 nm), (B) OA (7.9 ± 2.0 nm) 
and (C) DMSA (7.3 ± 1.8 nm) Fe3O4 NPs.  
TABLE I.  PROPERTIES OF OA AND DMSA FE3O4 NPS. AVERAGE SIZE 
AND AVERAGE DIAMETER OBTAINED FROM XRD PATTERN, DLS AND TEM 
IMAGE, RESPECTIVELY. MAGNETIC PROPERTIES ARE PRESENTED BY 






Average crystallite size (XRD) (nm) 9.75 9.75 
Average diameter (TEM) (nm) 7.9 ± 2.0 7.3 ± 1.8 
Average diameter 
(DLS) 
Dh (nm) 147.3 ± 5.5 57.1 ± 1.7 
PDI 0.25 ± 0.02 0.20 ± 0.01 
MS (emu.g
-1 Fe) 45 57 
 
To access the influence of DMSA and OA molecules in the 
heating generation ability of SPIONs, magnetic hyperthermia 
  
measurements were performed. Fig. 2 (B) represents the 
temperature variation obtained from magnetic hyperthermia 
test as a function of iron concentration for both OA and DMSA 
Fe3O4 NPs. For OA Fe3O4 NPs, we can observe a tendency of 
the heating ability of the NPs to stabilize for high iron 
concentrations. However, an exponential temperature increase 
is observed for DMSA Fe3O4 NPs. For the same iron 
concentration, these NPs can increase their temperature about 
2x than OA Fe3O4 NPs. From magnetic hyperthermia 
measurements it is possible to obtain not only the temperature 
variation but also to calculate the heating efficiency of the 
magnetic material. This parameter can be determined using the 
specific absorption rate (SAR). SAR values (Fig. 2 (C)) 
remained constant with increasing iron concentrations for both 
coated NPs. However, SAR values are found to be twice as 
low for OA Fe3O4 NPs compared to DMSA Fe3O4 NPs. These 
results can be explained by the relaxation modes of magnetic 
NPs. When a magnetic material is submitted to an alternating 
current (AC) magnetic field, exhibits both Brownian and Néel 
relaxations. When the NPs are in suspension both relaxation 
paths are present. Brownian relaxation occurs due to the ability 
of the particles to freely rotate. In this case, the bilayer formed 
around the iron oxide cores entrap the NPs thus eliminating 
their Brownian movements. Therefore, for OA Fe3O4 NPs the 
heat generation can only be attributed to Néel relaxation [15]. 
This could additionally explain the low MS observed in these 
samples. 
 
Figure 2.  Magnetic characterization (A) of naked, OA and DMSA Fe3O4 
NPs. (B) Generated temperature of OA and DMSA Fe3O4 NPs during 10 
min of AC magnetic field application with an intensity of 24 kAm−1 and 
418.5 kHz of frequency as a function of iron concentration. (C) Comparison 
of SAR values of OA and DMSA Fe3O4 NPs in water. The results are 
expressed as the average ± standard deviation for three independent 
experiments. 
B. Nanoparticles uptake and internalization in breast 
cancer cells 
A moderate toxicity is observed for high iron 
concentrations of around 1.0 and 2.5 mg.mL-1 for OA and 
DMSA Fe3O4 NPs, respectively (Fig. 3). These results provide 
important input to achieve a compromise between the use of 
OA and DMSA as SPIONs stabilizers and its impact on 
magnetic hyperthermia. 
Qualitative and quantitative internalization studies of OA 
and DMSA Fe3O4 NPs in MDA-MB-231 WT and MDA-MB-
231 STn cell lines were performed (Fig. 4). For the qualitative 
internalization study of Fe3O4 NPs, Prussian Blue Staining 
technique was performed in which uptake of NPs can be 
observed inside the cells [16]. Fig. 4 (A) shows that increasing 
the concentration of both NPs lead to a corresponding increase 
of their cellular internalization in both cell lines. 
 
Figure 3.  MDA-MB-231 WT and MDA-MB-231 STn cell lines viability 
after 24h exposition to (A) OA Fe3O4 NPs and (B) DMSA Fe3O4 NPs. 
Results are expressed as average ± standard deviation for at least three 
independent experiments. *p<0.05, **p<0.005, ****p<0.0001 compared to 
untreated control cells (UCC). 
 
Figure 4.  Bright field microscopy visualization of MDA-MB-231 WT (A) 
and MDA-MB-231 STn (B) cells incubated with OA and DMSA Fe3O4 NPs 
at iron concentrations ranging from 0.05 mg.mL-1 to 0.1 mg.mL-1. The blue 
color inside the cells represents the NPs uptake by contrast between the red 
and pink colors from the nuclei and cytoplasm staining, respectively. Scale 
bar represents 20 μm. (C, D) Intracellular iron content quantification by 
1,10-phenanthroline colorimetric method. Iron uptake is expressed as 
weight of iron per 1×106 cells and measured after 24 h (C) and 48 h (D) of 
OA and DMSA Fe3O4 NPs incubation in MDA-MB-231 WT and MDA-
MB-231 STn cell lines. Results are expressed as average ± standard 
deviation for at least three independent experiments. 
  
However, this increase is more significant in MDA-MB-
231 WT cells. Comparing OA and DMSA Fe3O4 NPs, it was 
particularly observed an increased internalization of DMSA 
Fe3O4 NPs due to the larger clusters inside both MDA-MB-231 
WT and STn cells (Figure 4 - vii to xii). In several cases it has 
been shown that a simple DMSA coating can improve uptake 
efficiency by three orders of magnitude, presumably by 
engendering the NPs with an anionic charge and resulting in 
nonspecific adsorption to the cell surface followed by 
endocytosis into the cell [17]. From Fig. 4 (B), which shows 
the internalization study of the two types of NPs in the MDA-
MB-231 STn cell line, two obvious conclusions can be drawn: 
(i), NPs internalization increases proportionally to the increase 
of OA (i to vi) and DMSA Fe3O4 NPs (vii to xii) 
concentrations and (ii), although it is slightly more pronounced 
in DMSA NPs, both NPs uptake in MDA-MB-231 STn cell 
line seems to be similar. 
This cell line expresses the carbohydrate antigen STn 
which occurs in approximately 80 % of human cancers [2]. 
STn is a short O-glycan terminated by a sialic acid named N-
Acetylneuraminic acid which can potentially establish a 
specific binding with the coating molecules of NPs. The 
carbonyl group (C=O) of this monosaccharide, may be 
available for a chemical bond sharing with the functional 
groups of OA and DMSA molecules A known method of NPs 
internalization in cells is based on a receptor-mediated 
approach, by which specific ligands are covalently linked to 
the coating molecules present on NPs to induce cell membrane 
receptor recognition followed by subsequent endocytosis 
[7,17]. Thus, two possible conclusions can be drawn: (i) OA 
and DMSA NPs internalization in MDA-MB-231 WT cell line 
is considered as non-specific, since the NPs can cross the cell 
membrane without any receptor involvement; (ii) the 
internalization of the same NPs in MDA-MB-231 STn cell line 
represents a NP-cell binding mediated by a receptor, which in 
this case is proposed to be the sialic acid present in the STn 
antigen. Therefore, the cellular internalization of NPs is much 
more effective in this last case. 
After 24 h (Fig. 4 (C)) and 48 h (Fig. 4 (D)) of incubation 
with OA and DMSA Fe3O4 NPs the iron uptake in cells shows 
a gradual increase, considering that from 0.1 to 0.5 mg.mL-1 
an exponential increase can be observed. This effect may be 
due to larger agglomerates accumulation in cells considering 
the higher concentration administered. Overall, it is possible to 
conclude that MDA-MB-231 STn cells can internalize more 
NPs compared to the WT cell line and that DMSA Fe3O4 NPs 
have a higher internalization rate than those stabilized with 
OA. Additionally, the concentration of absorbed iron is almost 
doubled after 48 h of incubation with NPs compared to the iron 
uptake values obtained after 24 h incubation. 
IV. CONCLUSIONS 
We have developed stable Fe3O4 NPs in solution and for 
that reason intracellular accumulation of these NPs is an 
important parameter to consider for biomedical applications. 
Qualitative and quantitative NPs internalization studies 
conclude that two types of cellular internalization may occur: 
(i) non-specific internalization of NPs, or (ii) receptor-
mediated internalization. In summary, the results herein 
obtained suggest that DMSA coated NPs are the most suitable 
for cancer treatment using magnetic hyperthermia. 
Considering the properties of DMSA coating, we envision the 
functionalization of the magnetic NPs surface with a 
monoclonal antibody against STn antigen to provide increased 
specificity to this system in the targeting of STn expressing 
cancer cells. In light of this results, it would be interesting to 
use this coated Fe3O4 NPs in other biomedical applications, 
such as contrast agents for MRI. 
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